Erythropoietin receptor contributes to melanoma cell survival in vivo.
about
Erythropoietin Pathway: A Potential Target for the Treatment of DepressionCurrent and future trials of targeted therapies in cutaneous melanomaCancer stem cells in basic science and in translational oncology: can we translate into clinical application?Effects of erythropoiesis-stimulating agents on fatigue- and anaemia-related symptoms in cancer patients: systematic review and meta-analyses of published and unpublished dataRecombinant human erythropoietin stimulates melanoma tumor growth through activation of initiation factor eIF4E.The erythropoietin/erythropoietin receptor signaling pathway promotes growth and invasion abilities in human renal carcinoma cells.Erythropoietin and cancer: the unintended consequences of anemia correctionErythropoietin improves the accumulation and therapeutic effects of carboplatin by enhancing tumor vascularization and perfusionEmerging EPO and EPO receptor regulators and signal transducers.Identification of Cell Type-Specific Differences in Erythropoietin Receptor Signaling in Primary Erythroid and Lung Cancer Cells.Human rhabdomyosarcoma cells express functional erythropoietin receptor: Potential therapeutic implications.Erythropoietin Stimulates Tumor Growth via EphB4.Contrasting effect of recombinant human erythropoietin on breast cancer cell response to cisplatin induced cytotoxicityErythropoietin-driven signalling and cell migration mediated by polyADP-ribosylation.Characterization of the erythropoietin/erythropoietin receptor axis in a rat model of liver damage and cholangiocarcinoma developmentPhenotyping of human melanoma cells reveals a unique composition of receptor targets and a subpopulation co-expressing ErbB4, EPO-R and NGF-R.AMPKα1 deletion in fibroblasts promotes tumorigenesis in athymic nude mice by p52-mediated elevation of erythropoietin and CDK2.Targeting EPO and EPO receptor pathways in anemia and dysregulated erythropoiesis.The lack of CD131 and the inhibition of Neuro-2a growth by carbamylated erythropoietin.Erythrocytosis in hepatocellular carcinoma portends poor prognosis by respiratory dysfunction secondary to mitochondrial DNA mutations.VE-Cadherin Disassembly and Cell Contractility in the Endothelium are Necessary for Barrier Disruption Induced by Tumor Cells.Local blockage of self-sustainable erythropoietin signaling suppresses tumor progression in non-small cell lung cancer.Anemia in Cutaneous Malignant Melanoma: Low Blood Hemoglobin Level is Associated with Nodal Involvement, Metastatic Disease, and Worse Survival.Erythropoietin enhances migration of human neuroblastoma cells: in vitro studies and potential therapeutic implications.
P2860
Q26750850-27A5347A-ABDB-4206-9523-F3236F75D0D1Q27022355-5E73AC42-A217-4CD4-8D56-2E22D670847DQ28081844-2AB892EB-8A48-4B3C-8E92-970302F86126Q30803363-C41C59C6-D95A-4BB7-A2E8-E133D4791256Q33728312-F8AAF116-5293-4F74-9FFA-5EF2E67D43F6Q34428148-8604DA19-C0BB-409D-8C3C-F0879F6F1E81Q34488415-AD3D7B3C-20F5-4709-B44C-B89F22BC2BC9Q35633372-AFB82F2A-42DC-4D0A-BB5D-680A38C62B31Q35692391-A1CA5BD8-0FB9-4E33-A845-66A80A6D33D8Q36095789-ADCA1F85-3873-4051-BCC3-45A65751D7BDQ36140572-3F9DFA1B-508C-4BF5-AC01-9EC0055C0DFBQ36275814-E3250B0F-595E-4550-A789-03534B655AEAQ36322416-2ACFE2BA-2C2B-47E9-A8DA-9E744CFE4DFBQ36387871-FA6871C4-651B-4699-B5B0-A556F6A31CD0Q36611934-8F18E47A-70AA-401D-89DE-66C48B23B861Q37529231-E17C3907-1C06-4355-9BCC-518A502F4687Q37619809-8911F022-55E4-4ABC-907E-0E5DD3237504Q38595266-ED3BA8A4-1B9F-4C7E-A336-AE0AF826E49CQ38912443-C047038F-33A0-4771-AD35-5298393F13A9Q39256165-B7A92DC1-D0C7-4B29-9C36-3708F3C97119Q42141595-AFF00BB2-CAD7-4423-B4E7-060FC75944CBQ47106745-4DC14470-7DE3-46D5-974D-83F121701C0AQ47561587-7D3B7DBA-7CE6-4477-9A22-750A3807E944Q54974179-AB681FBC-51D4-42FF-90F8-D0C3CA056E4B
P2860
Erythropoietin receptor contributes to melanoma cell survival in vivo.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Erythropoietin receptor contributes to melanoma cell survival in vivo.
@en
Erythropoietin receptor contributes to melanoma cell survival in vivo.
@nl
type
label
Erythropoietin receptor contributes to melanoma cell survival in vivo.
@en
Erythropoietin receptor contributes to melanoma cell survival in vivo.
@nl
prefLabel
Erythropoietin receptor contributes to melanoma cell survival in vivo.
@en
Erythropoietin receptor contributes to melanoma cell survival in vivo.
@nl
P2093
P2860
P356
P1433
P1476
Erythropoietin receptor contributes to melanoma cell survival in vivo
@en
P2093
A Pushparajan
M O Arcasoy
P2860
P2888
P304
P356
10.1038/ONC.2011.366
P407
P577
2011-08-22T00:00:00Z